Slowing Tecfidera Sales Increases Biogen's (BIIB) M&A Risk - Moody's

Go back to Slowing Tecfidera Sales Increases Biogen's (BIIB) M&A Risk - Moody's
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 220.84 -3.67 (1.63%)
Previous Close $224.51    52 Week High $333.65 
Open $221.15    52 Week Low $223.02 
Day High $223.82    P/E 28.28 
Day Low $219.82    EPS $7.81 
Volume 134,326